EverHeart Systems Now Corvion, Inc.

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

December 10, 2020

EverHeart Systems, developer of fully implanted mechanical circulatory support devices, announced today that it has changed its corporate name to Corvion, Inc. The name change has been chosen to further differentiate the Company’s products and mission from others in the mechanical circulatory assist device field and better reflects the company’s focus on high efficiency and wireless solutions for patients needing cardiac support.

“The new corporate name Corvion, Inc. – allows us to emphasize our world class pump efficiency and robust wireless charging technology that we believe will drive a new era in the use Left Ventricular Assist Devices (LVADs).  Patients will no longer be tethered to their controller and batteries, which limits their quality of life in so many ways. Decades have gone by with no viable fully implanted LVAD. We think it’s time for a radical change,” commented Greg S. Aber, CEO of Corvion, Inc.

The new name is effective immediately and will be implemented across the company’s products and presentations throughout next year.

spot_img

DON'T MISS

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.